Open Access Open Access  Restricted Access Subscription or Fee Access

A Critical Analysis on Impact of Clinical Pharmacist based Medication Reconciliation Practice among Cancer Patients-A Prospective Interventional Study.

Mekkanti Manasa Rekha

Abstract


Medication Reconciliation is defined as the process where the health care providers work with the patients to document communicate the comprehensive medication information by complete medication list and then reconciling it against what patient has been actually intended to take or taking in order to identify the drug related problems like drug interactions, medication errors and adverse drug reactions. Cancer patients are categorized as vulnerable population as they have many risk factors even cancer patients have been administered by various therapies like chemotherapy, biological agents, hormone therapy, supportive therapy that can  leads to poly pharmacy by increasing the risk of drug related problems so it is required to impose the medication reconciliation practice strictly to ensure whether medications are optimized or not and  to achieve desired therapeutic outcomes and in promotion of rational practice of drug usage .The present study involves in detail study of  anti-cancer drug usage through critical case and prescription analysis to identify, analyze and report the drug related problems during the course of treatment.261 patients were enrolled in the study. A total of 17 Adverse drug reactions were screened during study period with causality and severity assessment,  22 prescriptions comprised of potential drug interactions with 79medication errors .The present study clearly states the Impact and outcomes of clinical pharmacist based medication reconciliation practice in promotion of rational drug  usage and in minimization of drug related problems.

Keywords


Medication Reconciliation, Poly Pharmacy, Cancer patients, adverse drug reactions, Drug Interactions, Medication Errors.

Full Text:

PDF

References


Herledan C, Baudouin A, Larbre V, Gahbiche A, Dufay E, Alquier I. Clinical and economic impact of medication reconciliation in cancer patients: a systematic review. Support Care Cancer. 2020;28:3557–3569.

Kraus SK, Sen S, Murphy M, Pontiggia L. Impact of a pharmacy technician-centered medication reconciliation program on medication discrepancies and implementation of recommendations. Pharm Pract. 2017;15:901. doi: 10.18549/PharmPract.2017.02.901.

Damlien L, Davidsen N, Nilsen M, Godø A, Moger TA, Viktil KK. Drug safety at admission to emergency department: an innovative model for PRIOritizing patients for MEdication reconciliation (PRIOMER) Eur J Emerg Med. 2017;24:333–339.

Son H, Kim J, Kim C, Ju J, Lee Y, Rhie SJ. Pharmacist-led interdisciplinary medication reconciliation using comprehensive medication review in gynaecological oncology patients: a prospective study. Eur J Hosp Pharm. 2018;25(1):21–25.

Weingart SN, Cleary A, Seger A, Eng TK, Saadeh M, Gross A, et al. Medication reconciliation in ambulatory oncology. Jt Comm J Qual Patient Saf. 2007;33(12):750–757.

Vega TG-C, Sierra-Sánchez JF, Martínez-Bautista MJ, García-Martín F, Suárez-Carrascosa F, Baena-Cañada JM. Medication reconciliation in oncological patients: a randomized clinical trial. J Manag Care Spec Pharm. 2016;22:734–740.

Duffy AP, Bemben NM, Li J, Trovato J. Facilitating home hospice transitions of care in oncology: evaluation of clinical pharmacists' interventions, hospice program satisfaction, and patient representation rates. Am J Hosp Palliat Care. 2018;35(9):1181–1187. 8. Nguyen PAA, Enwere E, Gautreaux S, Lin H, Tverdek F, Lu M, et al. Impact of a pharmacy-driven transitions-of-care program on postdischarge healthcare utilization at a national comprehensive cancer center. Am J Health Syst Pharm. 2018;75:1386–1393.

Taché SV, Sönnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother 2011;45:977–89. 10.1345/aph.1P627.

Azim M, Khan A, Khan TM, et al.. A cross-sectional study: medication safety among cancer in-patients in tertiary care hospitals in KPK, Pakistan. BMC Health Serv Res 2019;19:583. 10.1186/s12913-019-4420-7.

Dorothy A, Yadesa TM, Atukunda E. Prevalence of medication errors and the associated factors: a prospective observational study among cancer patients at Mbarara Regional Referral Hospital. Cancer Manag Res 2021;13:3739–48. 10.2147/CMAR.S307001.

Baker GR, Norton PG, Flintoft V, et al.. The Canadian adverse events study: the incidence of adverse events among hospitalized patients in Canada. CMAJ 2004;170:1678–86. 10.1503/cmaj.1040498.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Research & Reviews: A Journal of Drug Design & Discovery